PMID- 19626358 OWN - NLM STAT- MEDLINE DCOM- 20100304 LR - 20240418 IS - 1436-6215 (Electronic) IS - 1436-6207 (Print) IS - 1436-6207 (Linking) VI - 49 IP - 1 DP - 2010 Feb TI - Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. PG - 1-9 LID - 10.1007/s00394-009-0042-x [doi] AB - BACKGROUND: There is evidence that disaccharide sucrose produce a greater increase in serum fructose and triglycerides (TGs) than the effect produced by their equivalent monosaccharides, suggesting that long-term exposure to sucrose or fructose + glucose could potentially result in different effects. AIM OF THE STUDY: We studied the chronic effects of a combination of free fructose and glucose relative to sucrose on rat liver. METHODS: Rats were fed either a combination of 30% fructose and 30% glucose (FG) or 60% sucrose (S). Control rats were fed normal rat chow (C). All rats were pair fed and were followed for 4 months. After killing, blood chemistries and liver tissue were examined. RESULTS: Both FG-fed- and S-fed rats developed early features of metabolic syndrome when compared with C. In addition, both diets induced hepatic alterations, including variable increases in hepatic TG accumulation and fatty liver, an increase in uric acid content in the liver, as well as an increase in hepatic levels of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha) measured in liver homogenates. CONCLUSIONS: Diets containing 30% of fructose either as free fructose and glucose, or as sucrose, induce metabolic syndrome, intrahepatic accumulation of uric acid and TGs, increased MCP-1 and TNF-alpha as well as fatty liver in rats. It will be relevant to determine clinically whether pharmacological reduction in uric acid levels might have a therapeutic advantage in the treatment of non-alcoholic fatty liver disease. FAU - Sanchez-Lozada, Laura G AU - Sanchez-Lozada LG AD - Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL, USA. lgsanchezlozada@gmail.com FAU - Mu, Wei AU - Mu W FAU - Roncal, Carlos AU - Roncal C FAU - Sautin, Yuri Y AU - Sautin YY FAU - Abdelmalek, Manal AU - Abdelmalek M FAU - Reungjui, Sirirat AU - Reungjui S FAU - Le, MyPhuong AU - Le M FAU - Nakagawa, Takahiko AU - Nakagawa T FAU - Lan, Hui Y AU - Lan HY FAU - Yu, Xuequing AU - Yu X FAU - Johnson, Richard J AU - Johnson RJ LA - eng GR - R01 HL068607/HL/NHLBI NIH HHS/United States GR - R01 HL068607-08/HL/NHLBI NIH HHS/United States GR - HL-68607/HL/NHLBI NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20090722 PL - Germany TA - Eur J Nutr JT - European journal of nutrition JID - 100888704 RN - 0 (Ccl2 protein, rat) RN - 0 (Chemokine CCL2) RN - 0 (Dietary Carbohydrates) RN - 0 (Dietary Sucrose) RN - 0 (Triglycerides) RN - 0 (Tumor Necrosis Factor-alpha) RN - 268B43MJ25 (Uric Acid) RN - 30237-26-4 (Fructose) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Body Fat Distribution MH - Chemokine CCL2/analysis MH - Dietary Carbohydrates/*administration & dosage MH - Dietary Sucrose/*administration & dosage MH - Energy Intake MH - Fatty Liver/*etiology/metabolism/pathology MH - Fructose/*administration & dosage MH - Glucose/*administration & dosage MH - Liver/chemistry MH - Male MH - Metabolic Syndrome/etiology MH - Rats MH - Rats, Sprague-Dawley MH - Triglycerides/analysis/blood MH - Tumor Necrosis Factor-alpha/analysis MH - Uric Acid/analysis/blood PMC - PMC2805058 MID - NIHMS149475 EDAT- 2009/07/25 09:00 MHDA- 2010/03/05 06:00 PMCR- 2010/02/01 CRDT- 2009/07/24 09:00 PHST- 2009/02/10 00:00 [received] PHST- 2009/07/05 00:00 [accepted] PHST- 2009/07/24 09:00 [entrez] PHST- 2009/07/25 09:00 [pubmed] PHST- 2010/03/05 06:00 [medline] PHST- 2010/02/01 00:00 [pmc-release] AID - 10.1007/s00394-009-0042-x [doi] PST - ppublish SO - Eur J Nutr. 2010 Feb;49(1):1-9. doi: 10.1007/s00394-009-0042-x. Epub 2009 Jul 22.